News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Sipai Health (00314.HK) Sells Pharmacy Business for Gain of RMB49.14 million
Sipai Health (00314.HK) announced that it has disposed of a 100% equity interest in Sipai Zhihe Technology to an independent third party, Dashenlin Pharmaceutical Group (603233.SH)...
Reset
Send
The window will close in 5 seconds
Sipai Health (00314.HK) Sells Pharmacy Business for Gain of RMB49.14 million
Close
Recommend
1
Positive
2
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Sipai Health (00314.HK)  0.000 (0.000%)   announced that it has disposed of a 100% equity interest in Sipai Zhihe Technology to an independent third party, Dashenlin Pharmaceutical Group (603233.SH)  +0.210 (+1.168%)   . The target company currently operates four pharmacies in Beijing and Hubei Province, and also runs a supply chain business providing services to pharmacies nationwide. The cash consideration for the transaction is RMB51.73 million. The estimated gain on disposal is approximately RMB49.14 million. (de/d)(HK stocks quote is delayed for at least 15 mins.) (A Shares quote is delayed for at least 15 mins.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.